Current Issue
August 2026 | Volume 25 | Issue 8
Editorials
Assessing Accuracy of ChatGPT in Identifying Contact Allergens in Commonly Prescribed Topical Therapies for Psoriasis
Comprehensive Analysis of Comorbidities Associated With Psoriasis Diagnosis in the MEPS National Cohort
Hidradenitis Suppurativa in Psoriasis Patients Treated With Biologics
Risankizumab Associated With Lower Incident Depression and Sleep Disorders in Psoriasis: A TriNetX Study
Original Articles
Decreased Nonmelanoma Skin Cancer Risk With Interleukin-17 and Interleukin-23 Inhibitors Versus TNF-α Inhibitors in Psoriasis
Background: People with psoriasis are at increased risk for nonmelanoma skin cancers (NMSC) and melanoma. Conventional immunosuppressants and TNF-α inhibitors may further increase skin malignanc...
Read MoreImpact of Intermittent Fasting, Keto Diet vs Continuous Caloric Restriction on Psoriasis Severity: A Systematic Review and Meta-Analysis Protocol
Background: Psoriasis is a chronic immune‑mediated inflammatory skin disease that is strongly associated with metabolic dysregulation and excess adiposity. Dietary strategies that reduce energy inta...
Read MoreImproved Sleep Quality in Psoriasis Patients Under Biologicals: A Prospective Observational Study
Background: Sleep disorders are an underappreciated component of psoriasis-related morbidity. Biologic therapies targeting IL-17 and IL-23 may improve sleep quality by reducing systemic inflammation a...
Read MoreClindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Acne: Pooled Analysis by Age and Sex
Background: Acne pathophysiology and presentation may differ by patient age or sex. In clinical trials, clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% (CAB) gel demonstrated efficacy...
Read MoreClascoterone Cream 1% is Safe and Effective for Papulopustular Rosacea: A Phase 2 Clinical Trial
Background: Papulopustular rosacea (PPR) is a chronic inflammatory facial dermatosis with a need for well-tolerated and effective topical therapies. Clascoterone cream 1% is an androgen receptor inhib...
Read MoreMolluscum Contagiosum in the Pediatric Population: Expert Consensus Guidance on Prevention and Treatment
Background: Molluscum contagiosum (MC), caused by the molluscum contagiosum virus, is a common viral skin infection in children. MC may persist for months to years and can substantially impair the qua...
Read MoreClinical Characteristics and Time to Onset of JAK-Inhibitor–Associated Acne: A Retrospective Chart Review Study
Background: Acne is a common cutaneous adverse event associated with Janus kinase (JAK) inhibitors, with incidence varying across agents. Substantial increase in JAK inhibitor use has been accompanied...
Read MoreUse of an Eczema Moisturizer or Cream Provides Immediate, Sustained Itch Relief in Eczema-Prone Individuals
Background: Eczema is a prevalent, chronic skin condition that affects up to 10% of adults globally and is characterized by recurrent eczematous lesions. Intense itch is often the most burdensome symp...
Read MoreSpeed of Response in Biologic Treatments for Moderate-to-Severe Plaque Psoriasis: Bayesian Network Meta-Analysis
Background: Psoriasis is a chronic inflammatory condition affecting approximately 3% of adults in the United States (US). While biologic therapies have transformed treatment for psoriasis, the speed a...
Read More
Features
Reddit for Redness: A Cross-Sectional Analysis of the r/Rosacea Forum
Reining in Medicare Spending on Skin Substitutes: What the 2026 Reforms Mean for Dermatology
GLP-1 Receptor Agonist Use for Diabetes Mellitus is Associated With Reduced Psoriasis Disease Severity
Biologics for Pediatric Hidradenitis Suppurativa: An Update on the Evolving Therapeutic Landscape
Sun Protection: Beyond Sunscreen
Case Reports
Improvement of Rosacea With Tirzepatide: A Case Report
Atopic Dermatitis Flare Following Initiation of Nemolizumab
Background: Atopic dermatitis (AD) is a chronic inflammatory skin disorder marked by intense pruritus and episodic flares. While nemolizumab, an interleukin-31 (IL-31) inhibitor, has demonstrated effi...
Read More
Departments
FULL SUPPLEMENT: Research on Generalized Pustular Psoriasis
Generalized pustular psoriasis (GPP) is a rare and potentially life-threatening disease of immunologic dysfunction. The pathophysiology of the disease was not well understood until recently. As a resu...
Read More
Supplements
INDIVIDUAL ARTICLE: Generalized Pustular Psoriasis: A Contemporary Review of Diagnosis, Pathophysiology, and IL-36 Pathway–Directed Management
Observations: Emerging epidemiologic, clinical, and real-world data establish GPP as a distinct disease entity associated with high rates of hospitalization, multisystem involvement, and increased mor...
Read More
